Molnupiravir, the oral pill for COVID-19, may actually be driving the emergence of new, potentially harmful, variants of the virus, according to a Wellcome Trust-funded study at the pre-print stage.
The government has given billions of dollars worth of subsidies and green mandates across the nation, despite "green" policies proving to be insufficient in times of need.
